01-08-2019 07:09 PM CET - Health & Medicine
Print

Tuberculosis Diagnostics Market Set for Rapid Growth And Trend by 2023 | Global Key Players - Abbott, Thermo Fisher Scientific, Cepheid, F. Hoffmann-La Roche AG, Hologic, Qiagen, Siemens

Press release from: Market Prognosis
Tuberculosis Diagnostics Market
Tuberculosis Diagnostics Market


Marketprognosis.com Publish a New Market Research Report On “Global Tuberculosis Diagnostics Market 2018 - 2023” which contains global key player’s survey information and forecast to 2023.

Overview of the Global Tuberculosis Diagnostics Market:

The Global Tuberculosis Diagnostics Market is expected to register a CAGR of nearly 4.5%, during the forecast period of 2018-2023.

Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies. The rising burden of tuberculosis and technological advancements play a crucial role in the growth of the market studied. Owing to the presence of a large, diversified patient population, rising prevalence of tuberculosis, and increasing healthcare infrastructure with an expanding private sector, Asia-Pacific has captured the largest market share.

Get a Sample Copy of this Report @ marketprognosis.com/sample-request/17134 .

According to the World Health Organization (WHO), about 10 million people are affected by tuberculosis, each year. Further, tuberculosis is the leading cause of death from a single infectious agent, ranking above HIV/AIDS. In addition, the WHO also states that the developing economies of Asia-Pacific, Africa, and Latin America account for the major burden related to tuberculosis, MDR TB, and TB associated with HIV, as of 2017. As per a 2017 report of the WHO, about 153,000 patients with MDR/rifampicin resistant (RR) TB were detected worldwide, in 2016. The developed countries, such as the United States and the United Kingdom are also struggling with the sluggish eradication of TB, as per the Centers for Disease Control and Prevention (CDC). Thus, a large section of the world population is affected with tuberculosis each year, thus boosting the growth of the tuberculosis diagnostics market.

The cost associated with tuberculosis diagnostics varies across laboratories and hospitals, globally. According to Unitaid, the use of GeneXpert MTB/RIF is primarily hampered owing to its high cost, particularly in the emerging markets. Further, China and India were among the countries that reflect higher costs of tests and increased expansion of the private sector. This is further linked with the unavailability of proper laboratory capacities. In some cases, the diagnostic tools have sub-optimal sensitivity and specificity, which are accompanied by the high costs of reference standard test and mycobacterial culture. Thus, over the forecast period, cost is expected to be one of the major restraining factors for the growth of the market studied.

Purchase this report online with 105 Pages, Top Key Players Analysis and List of Tables & Figure @ marketprognosis.com/buyReport/17134 .

Owing to the presence of a large, diversified patient population and high burden of tuberculosis, Asia-Pacific is expected to retain its market position, over the forecast period. Countries, such as India, China, Indonesia, and Afghanistan are among the top-priority countries for the control of communicable diseases, according to the WHO. China and India registered the highest number new cases of tuberculosis annually, followed by African and Latin American countries. The emerging economies are witnessing significant growth of the private sector, combined with the public sector, which provides considerable opportunities for the growth of the market studied.

Major Key Players:

1 Abbott

2 Becton, Dickinson and Company

3 Thermo Fisher Scientific Inc

4 Cepheid

5 F. Hoffmann-La Roche AG

6 Hain Lifescience GmbH

7 Hologic Corporation

8 Qiagen

9 Siemens and More……………

Any Query? Ask to our Expert @ marketprognosis.com/enquiry/17134 .

What Information does this report contain?

1 A detailed analysis of regulatory trends, drivers, industry pitfalls, challenges and growth opportunities for participants

2 Which are the leading market products, applications & regions and how will they perform by 2023?

3 What are the technologies & innovation trends, how will they evolve by 2023?

4 Which companies lead the industry, how are they positioned in the market in terms of sustainability, competency, production capacity and strategic outlook?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Tuberculosis Diagnostics Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

10 Future Outlook of the Market

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.

Thane – 421501

India.

sales@marketprognosis.com

+1 973 241 5193

www.marketprognosis.com

This release was published on openPR.
News-ID: 1480616 • Views: 317
More releasesMore releases

You can edit or delete your press release here: